Found: 13
Select item for more details and to access through your institution.
The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe.
- Published in:
- Scientific Reports, 2015, p. 9898, doi. 10.1038/srep09898
- By:
- Publication type:
- Article
Excess adiponectin in eyes with progressive ocular vascular diseases.
- Published in:
- FASEB Journal, 2021, v. 35, n. 2, p. 1, doi. 10.1096/fj.202001740RR
- By:
- Publication type:
- Article
Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2011, v. 49, n. 6, p. 959, doi. 10.1515/CCLM.2011.152
- By:
- Publication type:
- Article
Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone).
- Published in:
- Oxidative Medicine & Cellular Longevity, 2017, p. 1, doi. 10.1155/2017/9208489
- By:
- Publication type:
- Article
Dual inhibition of MEK and p38 impairs tumor growth in KRAS-mutated non-small cell lung cancer.
- Published in:
- Oncology Letters, 2019, v. 17, n. 3, p. 3569
- By:
- Publication type:
- Article
Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 2, p. 240, doi. 10.1007/s10147-015-0883-7
- By:
- Publication type:
- Article
Effects of progranulin on the pathological conditions in experimental myocardial infarction model.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-68804-7
- By:
- Publication type:
- Article
Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401).
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 14, p. 2113, doi. 10.1111/1759-7714.14048
- By:
- Publication type:
- Article
Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 8, p. 2351, doi. 10.1111/1759-7714.13532
- By:
- Publication type:
- Article
Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance.
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 710, doi. 10.3390/cancers16040710
- By:
- Publication type:
- Article
Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Evaluation of gefitinib efficacy according to body mass index, body surface area, and body weight in patients with EGFR-mutated advanced non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2015
- By:
- Publication type:
- journal article